BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 233828)

  • 1. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
    Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
    Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R; Kessous A; Mansour M; Camonis J; Rawls WE
    Prog Clin Biol Res; 1983; 132D():461-9. PubMed ID: 6314363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genital herpes and cervical cancer].
    Grebeniuk BN; Shuvaeva NI; Grigor'ev VV; Posevaia TA; Shubladze AK
    Vestn Dermatol Venerol; 1981 Feb; (2):9-12. PubMed ID: 6261479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
    Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
    Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
    [No Abstract]   [Full Text] [Related]  

  • 5. Genital Chlamydia trachomatis infections in patients with cervical atypia.
    Paavonen J; Vesterinen E; Meyer B; Saikku P; Suni J; Purola E; Saksela E
    Obstet Gynecol; 1979 Sep; 54(3):289-91. PubMed ID: 224353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
    Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
    J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 9. Uterine cervical dysplasia & herpes simplex virus.
    Luthra UK; Kotwani BG; Kochhar M; Khurana B; Seth P; Mohapatra LN; Mitra AB; Bhatnagar P; Prabhakar AK; Agarwal SS
    Indian J Med Res; 1983 Jul; 78 Suppl():60-6. PubMed ID: 6654432
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genital herpes and cervical cancer].
    Posevaia TA; Barinskiĭ IF
    Vopr Virusol; 1983; 28(5):518-30. PubMed ID: 6197814
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 12. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN; Vestergaard BF; Potter CW
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiological role of the herpes simplex virus in causing cervical cancer].
    Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
    Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.
    Skinner GR; Whitney JE; Hartley C
    Arch Virol; 1977; 54(3):211-21. PubMed ID: 196578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to herpes simplex virus (types 1 and 2) in Jamaican patients with cervical dysplasia and neoplasia.
    Prabhakar P; Rao BN; Hosang R; Narla VR; Persaud V
    West Indian Med J; 1984 Jun; 33(2):63-7. PubMed ID: 6091343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunohistological study on malignant and premalignant lesions of the uterine cervix associated with herpes simplex virus].
    Kubota T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2057-64. PubMed ID: 3025314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between Herpes simplex virus type 2 and carcinoma of the uterine cervix].
    Janda J
    Cesk Gynekol; 1973 Jul; 38(6):454-60. PubMed ID: 4354419
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
    Vestergaard BF
    Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aberrations & sister chromatid exchanges in relation to herpes simplex virus antibody in women with cervical dysplasia.
    Murty VV; Mitra AB; Sharma BK; Pratap M; Murthy NS; Luthra UK
    Indian J Med Res; 1986 Jan; 83():27-32. PubMed ID: 3009321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Formation of antibody to nucleocapsid and envelope of Herpes simplex virus hominis].
    Doerr HW; Schmitz H; Petersen EE
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):348-54. PubMed ID: 4154610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.